David Sali

Dave is OBJ's senior features writer with two decades of experience in the newspaper industry working for a variety of publications from community weeklies to major dailies. He is a four-time award-winning journalist by the Alliance of Area Business Publishers (AABP). He has received awards for best news feature, best scoop and best overall writer among medium-sized business publications.

Changing course: How Ian Fraser reimagined Run Ottawa’s business model for a pandemic world

When Ian Fraser took the top job at Run Ottawa in 2019, he had no idea how much he’d need to lean on every ounce of experience he’d gained in two decades as an entrepreneur.

Ottawa accounting firm Evolta poised to expand digital-first model to T.O.

Firm to launch a six-figure Google ad campaign in the Greater Toronto Area as it strives to reach goal of quadrupling revenues from $5 million to $20 million over the next five years.

Online student gains music to the ears of Orl​éans-based studio owner Chantal Hackett

Funded by a $10,000 grant from Desjardins Insurance, entrepreneur is poised to launch a new virtual singing academy.

Canadian Bank Note buys T.O.-based digital gaming software firm in $10M deal

Company's decision to acquire Bump is just one more step in its ongoing efforts to diversify its operations beyond printing currency. 

Kanata-made saliva collection kits will boost COVID-testing efforts, DNA Genotek says

Company announced this week that Health Canada has given the green light to its device for emergency use, meaning labs now have access to the spit kit for COVID-19 testing.

Ottawa’s rental apartment vacancy rate jumps to 3.9%: CMHC

More than 2,300 new rental units were added to the city’s inventory last year, yet the agency estimates that only about 890 of those were actually occupied.

Macadamian boss ‘handing off the keys’ after Gatineau software firm bought by U.S. company

Co-founder Fred Boulanger to step aside now that local tech enterprise is under the ownership of Nashville-based digital health-care services provider emids.

Ottawa bioscience firm Avivagen set to unveil immune-boosting supplements for humans

Fortified by $7.5 million in fresh funding, company is hoping a new version of its flagship product designed for people will help it finally achieve a market breakthrough.

‘A game-changer’: How Spartan retooled its patented rapid DNA test to tackle COVID-19

Ottawa biotech firm predicts revenues will top $200 million this year ​– and only rise from there.

Ottawa biotech startup gets US$1M boost in quest to find treatment for muscle-wasting disease

Scientists at Satellos Bioscience are working on a drug that will help regenerate muscle tissue in patients who suffer from Duchenne muscular dystrophy.

OBJ360 Sponsored

Guest Blogs

Social Galleries

Video

Event Calendar